Biotech Boom: Cell-Based Assays Revolutionizing Drug Development & Precision Medicine
The Cell-Based Assays Market is projected to grow from $35.3 billion in 2024 to $56.3 billion by 2029, at a 9.8% CAGR, driven by demand for drug discovery, ADME/toxicity testing, and precision ...
technologynetworks1y
Seahorse XF MitoTox Assay Kit for Mitochondrial Toxicity and Drug Safety Evaluation
Agilent Technologies is a global leader in life sciences, diagnostics and applied markets, recognized for uncompromising integrity in all they do. Their mission is to advance quality of life by ...
Business Wire1mon
CN Bio Launches PhysioMimix DILI Assay Kit: Human 24, for Enhanced Preclinical Toxicology Testing
Built upon CN Bio’s human-derived and highly characterized liver microphysiological system (MPS), the DILI assay kit provides robust, human-relevant insights into crucial drug safety parameters ...
PharmiWeb11d
Rising Demand for Regenerative Medicine to Drive Stem Cell Assays Market to $8.5 Bn by 2033 at a CAGR of 16.5% - Latest Report by TMR
The global Stem Cell Assays Market is experiencing unprecedented growth, driven by advancements in regenerative medicine, ...